Ligand Pharmaceuticals
LGND
#3636
Rank
NZ$6.18 B
Marketcap
NZ$314.31
Share price
-0.28%
Change (1 day)
51.31%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): NZ$0.11 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2024 the company made an earning of NZ$9.55 Million a decrease over its 2023 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.11 B1056.4%
2024 NZ$9.55 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.11 B4%
2021 NZ$0.11 B296.42%
2020 NZ$29.05 M-97.97%
2019 NZ$1.43 B275.62%
2018 NZ$0.38 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$75.82 M55.41%
2015 NZ$48.79 M36.87%
2014 NZ$35.64 M29.59%
2013 NZ$27.5 M1309.35%
2012 NZ$1.95 M-43.97%
2011 NZ$3.48 M-113.19%
2010 -NZ$26.42 Million59.86%
2009 -NZ$16.53 Million-61.33%
2008 -NZ$42.73 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$85.94 Million81.27%
2005 -NZ$47.42 Million
2003 -NZ$33.01 Million-20.6%
2002 -NZ$41.57 Million4.38%
2001 -NZ$39.83 Million-48.83%
2000 -NZ$77.83 Million-19.74%
1999 -NZ$96.97 Million-19.06%
1998 -NZ$0.12 Billion126.71%
1997 -NZ$52.85 Million-5.83%
1996 -NZ$56.12 Million136.23%
1995 -NZ$23.76 Million-33.97%
1994 -NZ$35.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
NZ$14.18 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.04 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$39.74 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.39 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.73 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.82 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.47 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.75 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA